GET THE APP

Understanding Nephropathy: Causes, Symptoms and Treatment
..

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

Short Communication - (2024) Volume 14, Issue 3

Understanding Nephropathy: Causes, Symptoms and Treatment

Merry Karstina*
*Correspondence: Merry Karstina, Department of Internal Medicine, University of Amsterdam, Amsterdam, Netherlands, Email:
Department of Internal Medicine, University of Amsterdam, Amsterdam, Netherlands

Received: 01-May-2024, Manuscript No. jnt-24-138117; Editor assigned: 02-May-2024, Pre QC No. P-138117; Reviewed: 17-May-0024, QC No. Q-138117; Revised: 23-May-2024, Manuscript No. R-138117; Published: 31-May-2024 , DOI: 10.37421/2161-0959.2024.14.509
Citation: Karstina, Merry. “Understanding Nephropathy: Causes, Symptoms and Treatment.” J Nephrol Ther 14 (2024): 509.
Copyright: © 2024 Karstina M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Nephropathy, often referred to as kidney disease, encompasses a range of conditions that affect the functionality and health of the kidneys. It's a serious health concern globally, with its prevalence increasing due to various factors such as the rise in diabetes, hypertension, and other chronic conditions. Understanding nephropathy, its causes, symptoms, and available treatments is crucial for both prevention and management.

Description

Diabetes is one of the leading causes of nephropathy. High blood sugar levels over time can damage the blood vessels in the kidneys, leading to nephropathy. This condition, known as diabetic nephropathy, is a common complication among individuals with both type 1 and type 2 diabetes. Uncontrolled high blood pressure can damage the small blood vessels in the kidneys, reducing their ability to filter waste products from the blood effectively. Over time, this can lead to kidney damage and nephropathy. This refers to inflammation of the glomeruli, the tiny filters in the kidneys responsible for filtering waste and excess fluids from the blood. Glomerulonephritis can be caused by infections, autoimmune diseases, or other systemic conditions. PKD is a genetic disorder characterized by the growth of cysts in the kidneys. These cysts can interfere with kidney function over time, leading to nephropathy and eventual kidney failure. Other factors that can contribute to nephropathy include certain medications (such as nonsteroidal anti-inflammatory drugs and some antibiotics), kidney infections, kidney stones, and prolonged obstruction of the urinary tract [1].

The symptoms of nephropathy can vary depending on the underlying cause and the stage of the disease. In the early stages, individuals may not experience any symptoms, and the condition may only be detected through routine medical tests. Swelling (edema) in the legs, ankles, feet, or face due to the kidneys' reduced ability to remove excess fluids from the body. Feeling unusually tired or lethargic, often due to anemia resulting from reduced production of erythropoietin, a hormone produced by the kidneys that stimulates red blood cell production. Excessive foaming or frothing of urine, which may indicate the presence of protein (albumin) in the urine, a sign of kidney damage. Changes in urination patterns, such as increased frequency, especially at night (nocturia), or decreased urine output. Hypertension, especially if it is difficult to control with medication, may indicate kidney damage. Treatment for nephropathy focuses on managing the underlying cause, slowing the progression of kidney damage, and preventing complications. Tight control of blood pressure through lifestyle modifications (such as a low-sodium diet, regular exercise, and weight management) and medications (such as angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers) can help slow the progression of nephropathy and reduce the risk of complications [2].

For individuals with diabetes, maintaining tight control of blood sugar levels is essential to prevent or delay the onset of diabetic nephropathy. This may involve medication, insulin therapy, dietary changes, and regular monitoring of blood glucose levels. Depending on the underlying cause of nephropathy, other medications may be prescribed to manage symptoms, reduce inflammation, or treat complications such as anemia or bone disease. In advanced stages of nephropathy, when the kidneys are no longer able to function adequately, dialysis may be necessary to remove waste products and excess fluids from the blood. In cases of end-stage kidney disease, kidney transplant surgery may be recommended as a treatment option. This involves replacing the diseased kidney with a healthy donor kidney. Follow a balanced diet low in sodium, saturated fats, and processed foods, exercise regularly, maintain a healthy weight, and avoid smoking and excessive alcohol consumption. Manage chronic conditions such as diabetes and hypertension effectively through medication, lifestyle modifications, and regular medical monitoring. Drink plenty of water and stay hydrated, but avoid excessive consumption of sugary or caffeinated beverages. If you have risk factors for kidney disease, such as diabetes or hypertension, or a family history of kidney disease, talk to your doctor about regular screening tests to monitor kidney function [3].

Kidney transplantation stands as a beacon of hope for individuals battling end-stage kidney disease. This surgical procedure involves replacing a failing kidney with a healthy one from a donor. While it offers a new lease on life for recipients, it also poses significant medical, ethical, and social considerations. Understanding the intricacies of kidney transplantation is vital for patients, donors, healthcare professionals, and society at large. Both recipients and potential donors undergo extensive medical and psychological evaluations to assess their suitability for the transplant. Recipients are evaluated for factors such as overall health, compatibility with the donor kidney, and willingness to adhere to post-transplant care. Donors undergo rigorous screening to ensure they are in good health and have compatible blood and tissue types. Compatibility between the donor and recipient is crucial to minimize the risk of organ rejection. Matching is based on factors such as blood type, tissue compatibility, and the presence of antibodies that could trigger rejection. The transplant surgery typically involves removing the diseased kidney from the recipient and replacing it with the healthy donor kidney. The procedure can be performed either as a traditional open surgery or laparoscopically, depending on the specific circumstances of the recipient and donor [4,5].

Conclusion

Nephropathy is a serious and potentially life-threatening condition that requires prompt diagnosis and management. By understanding the causes, symptoms, and treatment options for nephropathy, individuals can take proactive steps to protect their kidney health and reduce their risk of complications. Early detection, lifestyle modifications, and effective management of underlying conditions are key to slowing the progression of kidney disease and improving long-term outcomes for individuals with nephropathy.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Akil, Ammira Al-Shabeeb, Esraa Yassin, Aljazi Al-Maraghi and Elbay Aliyev, et al. "Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era." J Transl Med 19 (2021): 137.
  2. Google Scholar, Crossref, Indexed at

  3. Ciężki, Sebastian, Emilia Kurpiewska, Artur Bossowski and Barbara Głowińska-Olszewska. "Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children–From Disease Pathogenesis to Complications." Front Endocrinol 13 (2022): 890833.
  4. Google Scholar, Crossref, Indexed at

  5. Wu, Zhixian, Xiumin Xu, Jinquan Cai and Jin Chen, et al. "Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up." Cytotherapy 24 (2022): 421-427.
  6. Google Scholar, Crossref, Indexed at

  7. Papadopoulou-Marketou, Nektaria, Stavroula A. Paschou, Nikolaos Marketos and Sofia Adamidi, et al. "Diabetic nephropathy in type 1 diabetes." Minerva Medica 109 (2017): 218-228.
  8. Google Scholar, Crossref, Indexed at

  9. Samsu, Nur. "Diabetic nephropathy: Challenges in pathogenesis, diagnosis and treatment." BioMed Res International 2021 (2021).
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 784

Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward